Oncology
ASCO 2026: Chinese firms take a front seat in oncology, with...
Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Oncology
Cancer patients don’t care where the breakthrough happened. ...
National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.
Digital
Disruptive healthtech, personalisation & investment appetite
Bringing genuinely transformative healthcare innovations from concept to commercial reality is becoming increasingly complex.
Sales & Marketing
Are pharma teams ready for the next customer engagement mode...
The infrastructure is largely in place.
R&D
The changing multiple sclerosis landscape: Earlier diagnosis...
Multiple sclerosis (MS) is undergoing a meaningful evolution in how it is understood, diagnosed, and managed.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
